5 Micro-Cap Healthcare Stocks Insiders Are Buying
This article presents an overview of 5 Micro-Cap Healthcare Stocks Insiders Are Buying. For a detailed overview of such stocks read our article, 10 Micro-Cap Healthcare Stocks Insiders Are Buying...
Anixa Biosciences Inc (ANIX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 24,500 | $70,070 | +246% | 0% | |
| 2. | 23,400 | $66,924 | +41% | 0% | |
| 3. | Renaissance Technologies Jim Simons | 21,473 | $61,413 | +48% | 0% |
| 4. | Ancora Advisors Frederick Disanto | 1,522 | $4,353 | 0% | |
| 5. | Hurley Capital Charles Goldblum | 314 | $898 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.85 | 10,000 | Officer | 569,925 | 2025-06-04 | Filing | |
| $2.82 | 5,000 | Director | 120,000 | 2025-01-28 | Filing | |
| $3.00 | 1,000 | Director | 933,334 | 2025-01-24 | Filing | |
| $2.91 | 2,000 | Director | 932,334 | 2025-01-23 | Filing | |
| $3.01 | 2,000 | Director | 930,334 | 2025-01-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.57 | 11,800 | Officer, Director | 461,925 | 2023-07-31 | Filing | |
| $4.64 | 25,000 | Director | 25,000 | 2018-04-09 | Filing | |
| $3.10 | 210,000 | Director | 287,437 | 2016-08-24 | Filing | |
| $3.23 | 500 | Officer | 22,125 | 2016-06-02 | Filing | |
| $3.28 | 500 | Officer | 22,625 | 2016-06-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,392,906 | $3,983,711 | 0% | |
| 2. | 622,235 | $1,779,592 | 0.29% | |
| 3. | 614,272 | $1,756,818 | 0.01% | |
| 4. | 524,162 | $1,499,104 | 0% | |
| 5. | 469,517 | $1,342,819 | 0.03% |
News See All
5 Buy-Rated Stocks with Latest Insider Purchases
Robert James Wills, a director at Oncternal Therapeutics Inc (NASDAQ:ONCT), bought 3,086 shares of Oncternal Therapeutics Inc (NASDAQ:ONCT) at $8.96 per share.
12 Best Biotech Stocks to Buy Under $10
The past two years have been challenging for the biotech sector, based on the market performance of biotech equities. Compared to larger stock market indexes, biotechnology indices underperformed.
10 Best Biotech Stocks Under $10
In this article, we discuss the 10 best biotech stocks under $10.
Hedge Fund and Insider Trading News: Bill Ackman, Starboard Value, Eaton Vance Senior Income Trust (EVF), Bank of Marin Bancorp (BMRC), and More
Many of the biggest activist hedge funds saw blockbuster returns last year as concentrated wagers on companies from fast-food restaurants to real estate paid off.
Billionaire Hedge Funds
